Stock Analysis

Gulf Medical Projects Company (PJSC) Full Year 2023 Earnings: EPS: د.إ0.086 (vs د.إ0.052 in FY 2022)

ADX:GMPC
Source: Shutterstock

Gulf Medical Projects Company (PJSC) (ADX:GMPC) Full Year 2023 Results

Key Financial Results

  • Revenue: د.إ569.6m (up 13% from FY 2022).
  • Net income: د.إ59.8m (up 63% from FY 2022).
  • Profit margin: 11% (up from 7.3% in FY 2022). The increase in margin was driven by higher revenue.
  • EPS: د.إ0.086 (up from د.إ0.052 in FY 2022).
earnings-and-revenue-history
ADX:GMPC Earnings and Revenue History February 14th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Gulf Medical Projects Company (PJSC) shares are down 1.5% from a week ago.

Risk Analysis

You still need to take note of risks, for example - Gulf Medical Projects Company (PJSC) has 3 warning signs (and 2 which make us uncomfortable) we think you should know about.

Valuation is complex, but we're helping make it simple.

Find out whether Gulf Medical Projects Company (PJSC) is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.